Type I Error Probability Spending for Post-Market Drug and Vaccine Safety Surveillance With Poisson Data
暂无分享,去创建一个
[1] M. Kulldorff,et al. A Maximized Sequential Probability Ratio Test for Drug and Vaccine Safety Surveillance , 2011 .
[2] David L. DeMets,et al. Design and analysis of group sequential tests based on the type I error spending rate function , 1987 .
[3] Efficient Score Statistic in Drug and Vaccine Safety Surveillance , 2015 .
[4] S. Pocock. Group sequential methods in the design and analysis of clinical trials , 1977 .
[5] I R Silva,et al. Continuous versus group sequential analysis for post‐market drug and vaccine safety surveillance , 2015, Biometrics.
[6] B. Turnbull,et al. Group Sequential Methods with Applications to Clinical Trials , 1999 .
[7] K. K. Lan,et al. Discrete sequential boundaries for clinical trials , 1983 .
[8] N. Andrews,et al. Near real‐time vaccine safety surveillance using electronic health records—a systematic review of the application of statistical methods † , 2016, Pharmacoepidemiology and drug safety.
[9] Jennifer C. Nelson,et al. Statistical performance of group sequential methods for observational post-licensure medical product safety surveillance: A simulation study , 2012 .
[10] P. O'Brien,et al. A multiple testing procedure for clinical trials. , 1979, Biometrics.
[11] J. S. D. Cani,et al. Group sequential designs using a family of type I error probability spending functions. , 1990, Statistics in medicine.
[12] Christopher Jennison,et al. Statistical Approaches to Interim Monitoring of Medical Trials: A Review and Commentary , 1990 .
[13] W Katherine Yih,et al. Active Surveillance for Adverse Events: The Experience of the Vaccine Safety Datalink Project , 2011, Pediatrics.
[14] Christopher Jennison,et al. Interim analyses: the repeated confidence interval approach , 1989 .
[15] Robert T. Chen,et al. Active Surveillance of Vaccine Safety: A System to Detect Early Signs of Adverse Events , 2005, Epidemiology.
[16] Andrea J Cook,et al. Challenges in the design and analysis of sequentially monitored postmarket safety surveillance evaluations using electronic observational health care data , 2012, Pharmacoepidemiology and drug safety.
[17] Robert L Davis,et al. Real-Time Vaccine Safety Surveillance for the Early Detection of Adverse Events , 2007, Medical care.